American Society of Hematology

Fig. 1.

Fig. 1. Clinical outcome and MRD response. / Patients in CR but are MRD+ have a higher risk of progression than those in CR with no detectable MRD (log-rank test;P < .01).

Clinical outcome and MRD response.

Patients in CR but are MRD⁺ have a higher risk of progression than those in CR with no detectable MRD (log-rank test;P < .01).

This Feature Is Available To Subscribers Only

Sign In or Create an Account